The Killer or the Cure: Medicine Regulation in Cameroon in an Attempt to Wipe Out the Continuous Sale of Fakes

Authors

  • Harvey Awah Ambe

Keywords:

Regulation, medicines, COVID-19, hydrochloroquine, world health organisation

Abstract

Pharmaceutical drugs and traditional medicines plow the towns of Cameroon and are coming from different sources. Medicine regulation is covered by laws, decrees, orders etc., requiring authorisation in production, distribution, importation and marketing. The recent COVID-19 pandemic that has affected the entire world has come in with more health regulatory challenges in different parts of the world and Cameroon in particular. There has been a proliferation of different pharmaceutical and traditional drugs that have been supposedly said to cure the COVID 19 virus which in fact are fake. The result is that quacks have taken advantage of the pandemic to make false medicine prescription as well as the production of fake hydrochloroquine that has been tested by the World Health Organisation (WHO) to be part of the effective drugs that help in the cure of the virus. This paper thus seeks to establish the effectiveness of regulatory mechanisms in combatting dealings in fake medicines while drawing attention to regulatory insights on drug legislation. While making use of an in-depth content analysis and critical evaluation of primary and secondary data, this paper argues that the regulatory mechanism to combat dealings in fake medicines is weak and more stringent measures in relation to the observance of drug legislation is required. It is thus recommended that special tasks force be set up in every city to flush out unauthorised medicine dealers and also persecution of defaulters will go a long way to fight this ill.

References

Lezotre P.L., (2014), International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations, Elsevier Inc. At https://doi.org/10.1016/B978-0-12-800053-3.00001-X (accessed on the 28th day of April 2020).

Harvey A. Awah, The Regulation and Control of Retail Pharmaceutical Drugs in Cameroon, Ph.D thesis, Department of English Private Law, Faculty of Law and Political Science, The University of Bamenda, Cameroon, 2021.

This catastrophe influenced the development of medicines regulation far more than any event in history. Thalidomide was a sedative and hypnotic that first went on sale in Western Germany in 1956. Between 1958 and 1960 it was introduced in 46 different countries worldwide resulting in an estimated 10,000 babies being born with phocomelia and other deformities.

Li H., Liu S.-M., Yu X.-H., et al, (2020), Coronavirus disease 2019 (COVID-19): current status and future perspectives, International Journal of Antimicrobial Agents, https://doi.org/10.1016/j.ijantimicag.2020.105951, P.1.

Ahmad W., Shabbiri K., and Islam N., (2020), O-β-GlcNAcylation, Chloroquine and 2-Hydroxybenzohydrazine may hamper SARS-CoV-2 entry to human via inhibition of ACE2 phosphorylation at Ser787 but also induce disruption of virus-ACE2 binding, p. 3 at: https://www.researchgate.net/publication/340843901 (accessed on the 2nd day of April 2020)

Shereen M.A., Khan (S) et al, (2020), COVID-19 infection: Origin, transmission, and characteristics of human Coronaviruses, Journal of Advanced Research, p. 92.

Lowe (R.F) and Montagu (D), (2009), Legislation, Regulation, and Consolidation in the Retail Pharmacy Sector in Low Income Countries, Southern Med Review, Vol 2; Issue 2, p. 35.

Ibid.

Lezotre (P.L), Ibid.

Ndomondo (S.M) et al, (2017), Medicines Regulation in Africa: Current State and Opportunities, Pharmaceutical Medicine 31(2): DOI: 10.1007/s40290-017-0210-x, p. 382.

Galega S.D., and Fuah C.K., The Law on Pharmaceutical Product Liability in Context, Ibadan University Printery, 2018.

Galega S.D., (2000), “In the Wilderness at Dawn of the Millennium: The Untold Truth about Cameroonian Consumers and the Global Change”, the African Society of International and Comparative Law, pp 319-336. For extensive reading see Galega S.D., Cameroon Product Liability in Perspective: Lessons from Abroad, Lambert Academic Publishing, 2018.

Ratanawijitrasin S., and Wondemagegnehu E., Effective Drug Regulation: A multicountry study, Geneva: World Health Organisation, 4th edition, 2002, p. 12.

Butt Z.A., et al, (2005), Quality of pharmacies in Pakistan: a cross-sectional survey, International Journal of Quality Health Care, Vol. 17(4), p. 308.

Adikwu M.U., (1996), Sales practices of patent medicine sellers in Nigeria, Health Policy Plan, Vol. 11(2), p. 205.

Licence N°1135/A/MINSANTE/SG/DPM/SDP/SA of 27 may 2020 with P.O. Box 15249

See Order N°1722/A/MINSANTE/CAB of 18 June 2020 suspending the operating licence NKAH BIOMEDICAL EQUIPMENT SARL a Wholesale Distribution Medical Devices Company.

Decree N° 2013/093 of 03 April 2013 Organising the Ministry of Public Health lays down the rules of functioning of this department

See Article 18, supra.

Eghan K., and Daniel G., (2011), Assessment of the Pharmaceutical Management System in Cameroon. Submitted to the US Agency for International Development by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington, VA: Management Sciences for Health, p. 5.

Its head office is found in Yaounde, political capital of Cameroon, directly behind the Ministry of Finance and facing the National Museum.

The present Minister of Public Health is Dr. Malachie MANAOUDA.

This department of the Ministry of Public Health is detached from the main head office in Yaounde and is located at Mballa II.

www.minsante.gov.cm (accessed on the 11th day of October 2019).

Eghan K., and Daniel G., (2011), Loc.cit, p. 6.

Ibid

At www.minsante.gov.cm (accessed on the 11th day of October 2019)

See Article 17 of Decree No. 98/405 / PM of 22nd October 1998 setting the terms of approval and marketing of pharmaceutical products in Cameroon.

Eghan K., and Daniel G., (2011), Loc.cit, p. 6.

Ibid.

Ibid

Margareth N.S., et al (2017), Loc.cit, p. 384.

Ibid

Information gotten from the Ministry of Public Health.

Order No. 102/CAB/PM of 18th November 2019. on the creation of a National Multi-sectorial Commission for the Fight against Fake Medicine and Traffic in Illicit Pharmaceutical Products in Cameroon.

See Article 3 supra.

See Press Release No. D13-95/CP/MINSANTE/SG/DPML of 23rd March 2020

See Circular Letter No. D36-31/LC/MINSANTE/SG/DPML of 23rd March 2020 relating to the Control of Medical Prescription in the Treatment of the New Coronavirus.

See the Littoral Governor’s Regional Order No. 011/AR/C/SG/DAAJ of 2nd April placing a ban on the public consummation of alcohol in the Littoral Region.

The Minister of Public Health, Dr Manaouda Malachie briefing on the coronavirus pandemic in Cameroon, Equinox Television Channel, 7pm News on the 23rd day of March 2020.

JournalduCameroun, Cameroon/COVID-19: Health boss authorizes production of chloroquine tablets, 8 April 2020 at https://www.journalducameroun.com/en/cameroon-covid-19-health-boss-authorizes-manufacturing-of-chloroquine-tablets/ (accessed on the 2nd day of May 2020).

Cameroon News Agency (CAN), “COVID-19: Fake Chloroquine Circulating In Hospitals” at https://cameroonnewsagency.com/covid-19-fake-chloroquine-circulating-in-hospitals/ (accessed on the 2nd day of April 2020.

See Consultation No. 00000916 of 30th March 2020 of the Telecommunications Regulatory Board or the Ministry of Post and Telecommunications.

See Law No. 90-036 of 10th August 1990 relating to the Organisation and Practice of Medicine in Cameroon.

See Decree No. 92/261/PM of 17 July 1992 fixing the modalities of Application of certain Provisions of the Law No. 90-035 of 10th August 1990 relating to the Organisation and Practice of Medicine in Cameroon.

See Law No. 2016/007 of 12th July 2016 relating to the Penal Code of Cameroon.

See Law No. 90-036 of 10th August 1990 relating to the Organisation and Practice of Medicine in Cameroon, Law No. 90-035 of 10th August 1990 relating to the Organisation and Practice of the Pharmacy Profession in Cameroon as well Decree No. 92/261/PM of 17 July 1992 fixing the modalities of Application of certain Provisions of the Law No. 90-035 of 10th August 1990 relating to the Organisation and Practice of Medicine in Cameroon.

Section 36, ibid.

See Section 207 of the Penal Code

See Section 219, ibid.

See Section 228, ibid.

See Section 240, ibid.

See Section 258, ibid.

See section 258-1, ibid.

See Section 259, ibid.

See Section 260, ibid.

Harvey A. Awah, Djieufack Roland and Galega D. Samgena, (2021), “Liability For the Sale of Counterfeit Pharmaceutical Drugs in Cameroon”, IJLMH Vol. 4 (3) Page 3729–3740 DOI: https://doij.org/10.10000/IJLMH.11852

See Section 18, ibid.

See Section 18-1, ibid.

See Section 19, ibid.

See Section 20, ibid.

See Section 33, ibid.

See Section 34, ibid.

See Section 34-1, ibid.

See Section 35, ibid.

Published

2023-01-10

How to Cite

Harvey Awah Ambe. (2023). The Killer or the Cure: Medicine Regulation in Cameroon in an Attempt to Wipe Out the Continuous Sale of Fakes. Indian Journal of Health and Medical Law, 5(2), 15–25. Retrieved from https://lawjournals.celnet.in/index.php/ijhml/article/view/1166